The Journal of Immunology, Vol 155, Issue 1 316-324, Copyright © 1995 by American Association of Immunologists

ARTICLES

Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide

G Camussi, F Mariano, L Biancone, A De Martino, B Bussolati, G Montrucchio and PS Tobias
Department of Nephrology, Faculty of Medicine and Surgery, University of Pavia, Varese, Italy.

The biosynthesis of platelet-activating factor (PAF) during Gram- negative involves the interaction of LPS with the cells of the host. We have investigated the molecular mechanism that controls cell recognition and PAF biosynthetic response to LPS in human monocytes (MO), glomerular mesangial cells (MC), and HUVEC in culture. The synthesis of PAF by MO and MC involves two proteins, plasma LPS binding protein (LBP) and cell membrane CD14 (mCD14). As MO, MC were shown to express the mCD14 molecule by several mAbs. MO and mCD14-positive MC were stimulated to synthesize PAF either by the 63D3 and IOM-2 mAbs or by the natural ligand LBP-LPS complex. Moreover, LeuM3, 28C5, and 18E12 mAbs that were themselves unable to stimulate the synthesis of PAF blocked PAF synthesis initiated by LBP-LPS complex. LBP was required for synthesis of PAF by MO. In MC, which synthesize PAF also after stimulation by LPS alone, the LBP was shown to speed and significantly enhance the synthesis of PAF. The soluble form of CD14 (sCD14), when added to MO stimulated with LBP-LPS complexes, inhibited the synthesis of PAF possibly by competing with mCD14. In contrast, sCD14 was shown to be required for LPS-induced synthesis of PAF by HUVEC, which did not express mCD14. Therefore, membrane receptors (mCD14) and plasma soluble proteins (LBP and sCD14) may enable different human cell types to synthesize PAF after LPS stimulation.

This article has been cited by other articles:

				S. Noubir, Z. Hmama, and N. E. Reiner Dual Receptors and Distinct Pathways Mediate Interleukin-1 Receptor-associated Kinase Degradation in Response to Lipopolysaccharide: INVOLVEMENT OF CD14/TLR4, CR3, AND PHOSPHATIDYLINOSITOL 3-KINASE J. Biol. Chem., June 11, 2004; 279(24): 25189 - 25195. [Abstract] [Full Text] [PDF]

				G. F. Passos, E. S. Fernandes, M. M. Campos, J. G. V. C. Araujo, J. L. Pesquero, G. E. P. Souza, M. C. W. Avellar, M. M. Teixeira, and J. B. Calixto Kinin B1 Receptor Up-Regulation after Lipopolysaccharide Administration: Role of Proinflammatory Cytokines and Neutrophil Influx J. Immunol., February 1, 2004; 172(3): 1839 - 1847. [Abstract] [Full Text] [PDF]

				A. J. Tonks, A. Tonks, R. H. K. Morris, K. P. Jones, and S. K. Jackson Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine J. Leukoc. Biol., July 1, 2003; 74(1): 95 - 101. [Abstract] [Full Text] [PDF]

				T. E. N. Jonassen, M. Grabe, D. Promeneur, S. Nielsen, S. Christensen, and N. V. Olsen Lipopolysaccharide-Induced Acute Renal Failure in Conscious Rats: Effects of Specific Phosphodiesterase Type 3 and 4 Inhibition J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 364 - 374. [Abstract] [Full Text] [PDF]

				G. Montrucchio, G. Alloatti, and G. Camussi Role of Platelet-Activating Factor in Cardiovascular Pathophysiology Physiol Rev, October 1, 2000; 80(4): 1669 - 1699. [Abstract] [Full Text] [PDF]

				J. MORRISSEY, G. GUO, R. MCCRACKEN, T. TOLLEY, and S. KLAHR Induction of CD14 in Tubular Epithelial Cells During Kidney Disease J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1681 - 1690. [Abstract] [Full Text]

				Y.-T. Juang, W.-C. Au, W. Lowther, J. Hiscott, and P. M. Pitha Lipopolysaccharide Inhibits Virus-mediated Induction of Interferon Genes by Disruption of Nuclear Transport of Interferon Regulatory Factors 3 and 7 J. Biol. Chem., June 18, 1999; 274(25): 18060 - 18066. [Abstract] [Full Text] [PDF]

				S. FRANK, K. ZACHAROWSKI, G. M. WRAY, C. THIEMERMANN, and J. PFEILSCHIFTER Identification of copper/zinc superoxide dismutase as a novel nitric oxide-regulated gene in rat glomerular mesangial cells and kidneys of endotoxemic rats FASEB J, May 1, 1999; 13(8): 869 - 882. [Abstract] [Full Text]

				J. Hayashi, T. Masaka, and I. Ishikawa Increased Levels of Soluble CD14 in Sera of Periodontitis Patients Infect. Immun., January 1, 1999; 67(1): 417 - 420. [Abstract] [Full Text] [PDF]

				Y. Shen, C. Sultana, M. Arditi, K. S. Kim, and V. K. Kalra Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists Am J Physiol Endocrinol Metab, September 1, 1998; 275(3): E479 - E486. [Abstract] [Full Text] [PDF]

				G. Berntzen, T. H. Flo, A. Medvedev, L. Kilaas, G. Skjåk-Bræk, A. Sundan, and T. Espevik Clin. Vaccine Immunol., May 1, 1998; 5(3): 355 - 361. [Abstract]

				P. C. Giardina, T. Gioannini, B. A. Buscher, A. Zaleski, D.-S. Zheng, L. Stoll, A. Teghanemt, M. A. Apicella, and J. Weiss Construction of Acetate Auxotrophs of Neisseria meningitidis to Study Host-Meningococcal Endotoxin Interactions J. Biol. Chem., February 16, 2001; 276(8): 5883 - 5891. [Abstract] [Full Text] [PDF]